Reduced reimbursement threatens Australia's cardiac diagnostic centres

Australia's network of standalone cardiac diagnostic centres offers a community-friendly alternative to hospital-based testing. From suburban echocardiography clinics in Parramatta and Box Hill to community Holter monitoring services in regional Queensland, these facilities handle a significant share of non-invasive cardiac assessments. Yet the financial foundations supporting them are shifting, as reimbursement schedules fail to keep pace with rising clinical, staffing and equipment costs.

The Medicare Benefits Schedule sets the rebate the Australian Government pays for cardiac diagnostic procedures. When those rebates stagnate or fall in real terms, the impact ripples through every booking, staffing decision and equipment purchase. Standalone centres are particularly exposed because they operate without the cross-subsidies that public hospitals and large teaching institutions enjoy.

This pressure is reshaping cardiology access in ways patients and referrers are only beginning to feel. Longer wait times, reduced bulk billing, and the quiet closure of community services are emerging realities. Understanding how reduced reimbursement threatens standalone cardiac diagnostic centres is essential for anyone concerned about equitable cardiovascular care in Australia.

The Australian cardiac diagnostic landscape

Standalone cardiac diagnostic centres occupy a distinct place in Australian healthcare. They are typically owned by cardiologists, radiologists, or specialist sonographers and operate as accredited day-procedure or imaging facilities. Major streets around Westmead in Sydney, Epping in Melbourne's north, and Spring Hill in Brisbane are lined with such clinics, offering echocardiograms, exercise stress tests, ambulatory Holter monitoring, cardiac CT and cardiac MRI.

Most of these practices rely heavily on the Medicare rebate as their primary or sole revenue stream for diagnostic services. The indexation freeze of the previous decade meant rebates did not rise with inflation, wages or equipment costs for years. While indexation has since resumed, the base level remains modest, and any future adjustment that fails to match the real cost of delivering care functions as a cut in practice.

Professional bodies such as the Cardiac Society of Australia and New Zealand have repeatedly noted that reimbursement for complex cardiac imaging lags behind the sophistication of the technology. A cardiac MRI that takes an hour of scanner time and requires highly trained staff may attract a rebate only marginally higher than a 30-minute bedside echo performed decades ago.

Anatomy of a reimbursement cut

A reimbursement cut rarely arrives as a single dramatic reduction. More commonly, it appears as a failure to index, a redistribution of rebates through MBS review, or a tightening of claiming rules. For a standalone centre performing thousands of studies a year, the cumulative effect can be substantial.

Diagnostic Service	Approximate MBS Schedule Fee (AUD)	Estimated Real Cost to Deliver	Rebate as % of Cost
Transthoracic echocardiogram	~$230	$280–$320	70–82%
Exercise stress echocardiogram	~$260	$340–$400	65–76%
24-hour Holter monitor	~$120	$150–$180	67–80%
Cardiac CT (calcium score + angiogram)	~$500	$650–$750	67–77%
Cardiac MRI	~$850	$1,100–$1,300	65–77%

These figures illustrate the structural gap between what Medicare pays and what it costs to perform the test in a fully accredited environment. When rebate income covers only three-quarters of operating costs, every additional patient consumes practice capital rather than building it.

For many operators, the options are stark: reduce service hours, defer equipment upgrades, decline to bulk-bill concession card holders, or close. None of these choices serve patients well.

Patient access and out-of-pocket costs

When reimbursement fails to cover the true cost of a cardiac test, the shortfall is usually passed on as a gap fee. Bulk billing has historically been common in Australian diagnostic imaging, but rates have been declining. Recent Medicare data shows bulk-billing rates for specialist services and diagnostic imaging now sit below those for general practice.

For patients in growth corridors such as Sydney's North West, Melbourne's outer west, or the Sunshine Coast, this shift can be the difference between attending a follow-up appointment or delaying it. A patient referred for a stress echocardiogram after chest pain may face a $150 out-of-pocket cost, manageable for some households but prohibitive for pensioners, students, and families on lower incomes.

Reduced reimbursement also tightens appointment availability. Cardiologists and sonographers can only see a finite number of patients in a day, and if per-test revenue falls, the only levers left are volume and shorter appointments. Both compromise the careful, time-intensive nature of high-quality cardiac diagnostics.

The rural and remote challenge

Australia's vast geography magnifies the impact of any service closure. In regional centres such as Townsville, Launceston, Ballarat and Wagga Wagga, standalone cardiac diagnostic centres often serve entire catchments. When one closes, patients may travel hours to the nearest alternative, sometimes crossing state borders or flying to capital cities like Adelaide or Perth.

The tyranny of distance takes on a clinical dimension when cardiac diagnostics are involved. Heart failure monitoring, post-stent surveillance, and arrhythmia assessment all depend on timely local testing. Indigenous patients in remote parts of the Northern Territory and Western Australia already experience high rates of rheumatic heart disease and acute coronary syndromes, and any reduction in local diagnostic access deepens existing inequities.

Mobile cardiac diagnostic services fill some gaps, but they too depend on viable reimbursement. If the economics of running a mobile echo van across the Pilbara or western Queensland deteriorate, these services are among the first to be scaled back.

Workforce, technology, and quality

Cardiac diagnostics depend on a highly trained workforce. Sonographers, cardiac physiologists and specialist nurses require years of education and ongoing professional development. Australia already faces a shortage of accredited sonographers, and lower reimbursement makes it harder for standalone centres to match public hospital wages.

Equipment is another pressure point. A modern echocardiography machine can cost upwards of $200,000, and cardiac MRI scanners represent multi-million-dollar investments with annual service contracts running into the hundreds of thousands. If reimbursement does not support depreciation and replacement, practices delay upgrades, affecting image quality, diagnostic accuracy and accreditation compliance.

Quality assurance programs, mandatory continuing education and participation in clinical registries all add to overhead. Reduced reimbursement erodes the financial headroom needed to maintain these standards, even when clinicians are personally committed to them.

Policy and legal responses in Australia

Australia's policy environment offers several avenues for response, although each has limits. The Medicare Benefits Schedule Review Taskforce has examined cardiac diagnostic items and recommended changes, some implemented and others shelved. Professional societies such as the Cardiac Society of Australia and New Zealand, the Australian Sonographers Association, and the Royal Australian and New Zealand College of Radiologists regularly make submissions to government consultations on rebate levels.

At the state level, public hospital outpatient departments and community health services sometimes contract with private standalone centres to clear waiting lists. These contracts can buffer against Medicare inadequacy, but they are not available everywhere and are vulnerable to budget cycles.

Legal recourse for individual centres is limited, as MBS rebates are set by regulation. However, the Health Insurance Act 1973 shapes how services are marketed and billed, and any change in rebate policy must pass through Federal Executive Council processes that allow for stakeholder input.

Pathways forward for patients and the profession

Meaningful change will require action from clinicians, patients and policy makers. Both groups have practical steps they can take today.

Steps patients can take to protect access:

• Ask which diagnostic centre bulk-bills and which carries gap fees before booking any test
• Request a written quote for any service not fully covered by the Medicare rebate
• Share stories of delayed care or travel hardship with local federal MPs and senators
• Support consumer advocacy groups such as the Heart Foundation that lobby on access issues
• Clarify private health insurance gap structures before assuming a test is covered

Steps clinicians and centres can take to safeguard services:

• Submit detailed cost data to the Department of Health and Aged Care during MBS reviews
• Engage the Cardiac Society of Australia and New Zealand in coordinated advocacy
• Publish transparent fee schedules that show the gap between the rebate and the cost of delivery
• Pursue state and territory health service contracts where available to diversify income
• Invest in training the next generation of sonographers and cardiac physiologists

The viability of standalone cardiac diagnostic centres is not a niche concern. These facilities underpin early detection, ongoing monitoring and timely intervention for millions of Australians living with or at risk of heart disease. If reimbursement continues to lag behind the real cost of quality care, access will not disappear overnight, but it will erode quietly, neighbourhood by neighbourhood. Cardiologists, sonographers, practice managers and patients all have a stake in making the case for fair, indexed funding. Speak with your local federal MP, share your story, and back the professional bodies advocating for sustainable cardiac diagnostics across Australia.